BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 34 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,269,963 | +20771222.9% | 438,214 | -3.9% | 0.02% | – |
| Q4 2022 | $35 | -99.9% | 455,775 | +11.5% | 0.00% | – |
| Q3 2022 | $41,000 | -64.7% | 408,945 | -64.8% | 0.00% | – |
| Q2 2022 | $116,000 | +39.8% | 1,160,780 | +51.5% | 0.00% | – |
| Q1 2022 | $83,000 | -47.8% | 765,955 | -19.7% | 0.00% | – |
| Q4 2021 | $159,000 | -45.4% | 953,533 | +56.4% | 0.00% | -100.0% |
| Q3 2021 | $291,000 | +7175.0% | 609,776 | +8697.8% | 0.00% | – |
| Q1 2021 | $4,000 | – | 6,931 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 100,224,000 | $60,134,000 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $47,402,000 | 1.06% |
| Affinity Asset Advisors, LLC | 7,500,000 | $4,380,000 | 0.70% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,229,000 | $28,932,000 | 0.67% |
| Context Capital Management, LLC | 16,489 | $9,850,000 | 0.64% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 6,000,000 | $3,444,000 | 0.46% |
| TFG Asset Management GP Ltd | 15,000,000 | $8,942,000 | 0.41% |
| WOLVERINE ASSET MANAGEMENT LLC | 58,069,000 | $33,968,000 | 0.33% |
| SILVERBACK ASSET MANAGEMENT LLC | 4,000,000 | $2,333,000 | 0.32% |
| Ionic Capital Management LLC | 4,500,000 | $2,676,000 | 0.30% |